A carregar...
Anti-infective monoclonal antibodies: perils and promise of development
So far, most monoclonal antibodies have been developed for treating cancer or immunological diseases. However, the global spread of infections such as West Nile and corona viruses, and the need to address the potential threat of bioterrorism, has boosted public interest in, and government support of...
Na minha lista:
| Publicado no: | Nat Rev Drug Discov |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7097328/ https://ncbi.nlm.nih.gov/pubmed/16518372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd1987 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|